25 Recruiting Studies Using Aldesleukin
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Aldesleukin
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
š USC / Norris Comprehensive Cancer Center ā Los Angeles, California
Clear Cell Renal Cell Carcinoma
View Study & Checklist āTBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
š Moffitt Cancer Center ā Tampa, Florida
Squamous Cell Carcinoma of Head and Neck
View Study & Checklist āAldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
š Mayo Clinic in Rochester ā Rochester, Minnesota
Clinical Stage IV Gastric Cancer AJCC v8
View Study & Checklist āGenetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
š Roswell Park Cancer Institute ā Buffalo, New York
Recurrent Fallopian Tube Carcinoma
View Study & Checklist āGenetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
š M D Anderson Cancer Center ā Houston, Texas
Metastatic Melanoma
View Study & Checklist āLN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
š M D Anderson Cancer Center ā Houston, Texas
Bone Sarcoma
View Study & Checklist āAutologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Metastatic Solid Cancers
View Study & Checklist āGene and Vaccine Therapy in Treating Patients With Advanced Malignancies
š University of California at Los Angeles (UCLA ) ā Los Angeles, California
Malignant Neoplasm
View Study & Checklist āA Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
š University of Chicago Medicine Comprehensive Cancer Center ā Chicago, Illinois
Ovarian Cancer
View Study & Checklist āAutologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
š Ohio State University Comprehensive Cancer Center ā Columbus, Ohio
Locally Advanced Gastrointestinal Stromal Tumor
View Study & Checklist āStudy of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2RĪ± Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
š Sylvester Comprehensive Cancer Center - Miami ā Miami, Florida
Advanced Solid Tumor
View Study & Checklist āA Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Melanoma
View Study & Checklist āA Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
š Research Site ā Duarte, California
Relapsed or Refractory Multiple Myeloma
View Study & Checklist āAutologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Malignancy, Hematologic
View Study & Checklist āAdministering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Pancreatic Cancer
View Study & Checklist āE7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Cervical Cancer
View Study & Checklist āKK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
š Rutgers Cancer Institute ā New Brunswick, New Jersey
Gastric Cancer
View Study & Checklist āAdministration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Endocrine Tumors
View Study & Checklist āT Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Advanced Non-Small Cell Lung Cancer
View Study & Checklist āA2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
š USC / Norris Comprehensive Cancer Center ā Los Angeles, California
Triple Negative Breast Cancer
View Study & Checklist āLow-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
š Emory University/Winship Cancer Institute ā Atlanta, Georgia
Lung Non-Small Cell Carcinoma
View Study & Checklist āPhase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Metastatic Melanoma
View Study & Checklist āImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Metastatic Colorectal Cancer
View Study & Checklist āAdministering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
š National Institutes of Health Clinical Center ā Bethesda, Maryland
Pancreatic Cancer
View Study & Checklist āE7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
š Rutgers Cancer Institute ā New Brunswick, New Jersey
HPV-Associated Cervical Carcinoma
View Study & Checklist ā